Literature DB >> 19103733

Is pain intensity a predictor of the complexity of cancer pain management?

Robin L Fainsinger1, Alysa Fairchild, Cheryl Nekolaichuk, Peter Lawlor, Sonya Lowe, John Hanson.   

Abstract

PURPOSE: The lack of a standardized cancer pain (CP) classification system prompted the development of the Edmonton Classification System for Cancer Pain (ECS-CP). Its five features have demonstrated value in predicting pain management complexity. Pain intensity (PI) at initial assessment has been proposed as having additional predictive value. We hypothesized that patients with moderate to severe CP would take longer to achieve stable pain control, use higher opioid doses, and require more complicated analgesic regimens than would patients with mild CP at initial assessment.
METHODS: A secondary analysis of a multicenter ECS-CP validation study involving patients with advanced cancer was conducted (n = 591). Associations between PI and length of time to stable pain control (Cox regression), final opioid dose (Kruskal-Wallis one-way analysis of variance), and number of adjuvant modalities (chi(2)) were calculated. PI at initial assessment was defined using a numerical scale as mild (0 to 3), moderate (4 to 6), or severe (7 to 10).
RESULTS: Patients with moderate and severe pain required a significantly longer time to achieve stable pain control (P < .0001). PI was a significant predictor of length of time to stable pain control in the univariate regression analysis. The four significant predictors in the multivariate model were moderate and severe PI (P < .0001), age (P = .001), and neuropathic pain (P = .002). Patients with moderate to severe pain required significantly higher final opioid doses (P < .0001) and more adjuvant modalities (P = .015).
CONCLUSION: PI at initial assessment is a significant predictor of pain management complexity and length of time to stable pain control. Incorporation of this feature into the ECS-CP needs additional consideration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19103733     DOI: 10.1200/JCO.2008.17.1660

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  24 in total

1.  Development and cross-validation of the in-hospital mortality prediction in advanced cancer patients score: a preliminary study.

Authors:  David Hui; Kelly Kilgore; Bryan Fellman; Diana Urbauer; Stacy Hall; Julieta Fajardo; Wadih Rhondali; Jung Hun Kang; Egidio Del Fabbro; Donna Zhukovsky; Eduardo Bruera
Journal:  J Palliat Med       Date:  2012-06-04       Impact factor: 2.947

2.  Cancer pain--progress and ongoing issues in Europe.

Authors:  Stein Kaasa; Sebastiano Mercadante; Augusto Caraceni
Journal:  Pain Res Manag       Date:  2009 Sep-Oct       Impact factor: 3.037

3.  Cancer pain--progress and ongoing issues in Canada.

Authors:  Sharon Watanabe; Yoko Tarumi
Journal:  Pain Res Manag       Date:  2009 Sep-Oct       Impact factor: 3.037

Review 4.  [Chemotherapy-induced peripheral neuropathy and neuropathic pain].

Authors:  U Schuler; S Heller
Journal:  Schmerz       Date:  2017-08       Impact factor: 1.107

5.  Which factors can aid clinicians to identify a risk of pain during the following month in patients with bone metastases? A longitudinal analyses.

Authors:  Ragnhild Habberstad; M J Hjermstad; C Brunelli; S Kaasa; M I Bennett; K Pardon; P Klepstad
Journal:  Support Care Cancer       Date:  2018-08-13       Impact factor: 3.603

6.  Achievement of personalized pain goal in cancer patients referred to a supportive care clinic at a comprehensive cancer center.

Authors:  Shalini Dalal; David Hui; Linh Nguyen; Ray Chacko; Cheryl Scott; Lynn Roberts; Eduardo Bruera
Journal:  Cancer       Date:  2011-12-16       Impact factor: 6.860

Review 7.  A personalized approach to assessing and managing pain in patients with cancer.

Authors:  David Hui; Eduardo Bruera
Journal:  J Clin Oncol       Date:  2014-05-05       Impact factor: 44.544

8.  Individualized pharmacological treatment of oral mucositis pain in patients with head and neck cancer receiving radiotherapy.

Authors:  Ingrid Stenstrom Ling; Britt Larsson
Journal:  Support Care Cancer       Date:  2010-07-25       Impact factor: 3.603

9.  Determinants of pain severity changes in ambulatory patients with cancer: an analysis from Eastern Cooperative Oncology Group trial E2Z02.

Authors:  Fengmin Zhao; Victor T Chang; Charles Cleeland; James F Cleary; Edith P Mitchell; Lynne I Wagner; Michael J Fisch
Journal:  J Clin Oncol       Date:  2013-12-23       Impact factor: 44.544

10.  Prevalence and correlates of pain in the Canadian National Palliative Care Survey.

Authors:  Keith G Wilson; Hervey Max Chochinov; Pierre Allard; Srini Chary; Pierre R Gagnon; Karen Macmillan; Marina De Luca; Fiona O'Shea; David Kuhl; Robin L Fainsinger
Journal:  Pain Res Manag       Date:  2009 Sep-Oct       Impact factor: 3.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.